On November 18, FactSet Research fell 4.07% in Regular Trading, trading at $319.36 per share, with turnover of $63.8515 million.
The clearest catalyst in recent coverage is a renewed valuation debate after the company reaffirmed its fiscal 2027 outlook and presented medium-term targets at its Investor Day, while several brokerages kept neutral or hold-style views despite modest target-price increases.
FactSet said its medium-term framework through fiscal 2029 includes organic revenue CAGR of about 6%, adjusted diluted EPS CAGR of about 10%, and adjusted operating margin of at least 36%. The company also highlighted AI and data expansion through partnerships with Carbon Arc and Hamilton Lane. However, recent market commentary argued the shares could still be overvalued after the latest AI and data initiatives. Supporting that cautious tone, Morgan Stanley kept Equal Weight, RBC maintained Hold with a $304 target, and broader analyst consensus remained around Hold, helping explain pressure on the stock despite steady strategic updates.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments